Printer Friendly
The Free Library
14,506,104 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Sanko Junyaku Patents Its Proprietary Gene Amplification Method PALSAR in EU.


Tokyo, Japan, Sept 12, 2005 - (JCNN) - Sanko Junyaku announced on September 12 that its proprietary gene amplification method was officially patented in the EU as of September 7.

Numbered 1002877 in the Patent Gazette, the patented method named Probe Alternation Link Self-Assembly Reaction (PALSAR), uses two DNA probes that cover three complementary areas to amplify genetic signals by repeating hybridization hybridization /hy·brid·iza·tion/ (hi?brid-i-za´shun)
1. crossbreeding; the act or process of producing hybrids.

2. molecular hybridization

3.
. No nucleic-acid synthesizing enzyme is needed for hybridization.

The PALSAR method can react in a short time (30 seconds to 30 minutes) at a constant temperature (40 to 70 degrees centigrade). It can detect targeted DNA DNA: see nucleic acid.
DNA
 or deoxyribonucleic acid

One of two types of nucleic acid (the other is RNA); a complex organic compound found in all living cells and many viruses. It is the chemical substance of genes.
 and RNA RNA: see nucleic acid.
RNA
 in full ribonucleic acid

One of the two main types of nucleic acid (the other being DNA), which functions in cellular protein synthesis in all living cells and replaces DNA as the carrier of genetic
 highly accurately.

The method is expected to be used in a wide range of applications including medicine, food, environment, agriculture and stockbreeding stock·breed·ing  
n.
The breeding and raising of livestock.



stockbreed
. Currently, Sanko Junyaku's subsidiary Palma Palma or Palma de Mallorca (päl`mä thā mälyôr`kä), city (1990 pop. 325,120), capital of Majorca island and of Baleares prov., Spain, on the Bay of Palma.  Bee'Z Research Institute is working on research on PALSAR with a view to commercializing diagnostic agents for infectious diseases.

Source: JCN http://www.japancorp.net

Copyright [c] 2005 Japan Corporate News Network. All rights reserved.
COPYRIGHT 2005 Japan Corporate News Network K.K.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2005, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:JCNN News Summaries
Date:Sep 13, 2005
Words:160
Previous Article:TOTO Verifies Anti-cancer Property of Photocatalytic Titanium Dioxide Particle.
Next Article:MediBIC, Kazusa DNA Research Institute to Collaborate in New Drug Development.



Related Articles
VYSIS SHIPS GENOSENSOR MICROARRAY SYSTEM FOR GENOMIC RESEARCH.
ENZO BIOCHEM GETS NEW PATENT ALLOWANCES IN U.S/CANADA.
ONLINE PROGRAM ACCELERATES MEDICAL RESEARCH PROGRAMS.(Product Announcement)
Molecular Approaches to Diagnosing and Managing Infectious Diseases: Practicality and Costs.(Statistical Data Included)
Use molecular tools to determine ability of probiotics to hinder pathogens.
Enzo Life Sciences Launches New Advanced Amplification Technology for Gene Expression Analysis Studies.
The end of the age of innocence.(Competition)
Sysmex to Introduce New Analyzer for Detecting Breast Cancer Lymph-Node Metastasis to European Market.
Sanko Junyaku, Eisai and Fujirebio Sign Joint Research Agreement for Development of New KL-6 Test Kit.
Enzo Biochem Acquires License to Six Key RNA Amplification Patents.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles